ライフサイエンスコーパス: Japanese encephalitis

1 t viral-vectored vaccine for humans, against Japanese Encephalitis.

2 assess the efficacy of inteferon alfa-2a in Japanese encephalitis.

3 did not improve the outcome of patients with Japanese encephalitis.

4 er evaluation as a candidate vaccine against Japanese encephalitis.

5 novel live-attenuated viral vaccine against Japanese encephalitis.

6 s) in 112 Vietnamese children with suspected Japanese encephalitis, 87 of whom had serologically conf

7 own inteferon alfa has antiviral activity on Japanese encephalitis and other flaviviruses; therefore,

8 an be reliably prevented by vaccination (eg, Japanese encephalitis and rabies).

9 Vaccines are available for yellow fever, Japanese encephalitis and tick-borne encephalitis and se

10 genes of heterologous flaviviruses, such as Japanese encephalitis and West Nile viruses.

11 Louis encephalitis, Japanese encephalitis, and dengue viruses.

12 Flaviviruses such as West Nile, Japanese encephalitis, and tick-borne encephalitis (TBEV

13 of children admitted to hospital with acute Japanese encephalitis, and were confirmed serologically.

14 is closely related to yellow fever, dengue, Japanese encephalitis, and West Nile viruses, and vaccin

15 to the mosquito-borne yellow fever, dengue, Japanese encephalitis, and West Nile viruses, and vaccin

16 ccines have also been tested against dengue, Japanese encephalitis, and West Nile viruses.

17 Since it emerged in Japan in the 1870s, Japanese encephalitis has spread across Asia and has bec

18 ; interferon alpha was not effective against Japanese encephalitis in a double-blind placebo-controll

19 Japanese encephalitis is a major cause of death and disa

20 Japanese encephalitis is an acute zoonotic, mosquito-bor

21 Although an effective vaccine for Japanese encephalitis is available, hundreds of millions

22 Japanese encephalitis is characterized by extensive infl

23 Japanese encephalitis (JE) causes at least 10 000 deaths

24 Japanese encephalitis (JE) is a vaccine-preventable acut

25 Japanese encephalitis (JE) is the leading cause of viral

26 The live-attenuated Japanese encephalitis (JE) vaccine (JE-CV; IMOJEV) induc

27 Live attenuated SA14-14-2 Japanese encephalitis (JE) vaccine has been safe and eff

28 Japanese encephalitis (JE) virus (JEV) is an important c

29 A chimeric yellow fever (YF) virus/Japanese encephalitis (JE) virus vaccine (ChimeriVax-JE)

30 Similarly, the NS2B-NS3(178) protease of Japanese encephalitis (JE) virus, when substituted for t

31 ChimeriVax-Japanese encephalitis (JE), the first live- attenuated v

32 world population lives in areas with endemic Japanese encephalitis (JE).

33 Selectivity was validated using Japanese Encephalitis NS1, a homologous and potentially

34 ng polio, measles and rubella, yellow fever, Japanese encephalitis, rotavirus, and invasive bacterial

35 heir specificity in tests with yellow fever, Japanese encephalitis, St.

36 r, dengue, West Nile, St Louis encephalitis, Japanese encephalitis, tick-borne encephalitis, Kyasanur

37 Dengue, Japanese encephalitis, tick-borne encephalitis, yellow f

38 Vax-JE is a live, attenuated vaccine against Japanese encephalitis, using yellow fever (YF) 17D vacci

39 ive antibody titres from a prior inactivated Japanese encephalitis vaccination enhanced yellow fever

40 three) to receive two doses 1 month apart of Japanese Encephalitis vaccine (controls), 4CMenB, or one

41 at a regimen of two doses of live-attenuated Japanese encephalitis vaccine, administered 1 year apart

42 Yellow fever and Japanese encephalitis vaccinees were less reactive in th

43 Current Japanese encephalitis vaccines are derived from strains

44 cation in domesticated animals, as seen with Japanese encephalitis, Venezuelan equine encephalitis, a

45 rresponding genes of an attenuated strain of Japanese encephalitis virus (JE), SA14-14-2.

46 ll eight live attenuated vaccines, including Japanese encephalitis virus (JEV) (SA-14-14-2), varicell

47 virus (TBEV), yellow fever virus (YFV), and Japanese encephalitis virus (JEV) and by comparing the r

48 y for the presumptive serodiagnosis of acute Japanese encephalitis virus (JEV) and West Nile virus (W

49 Four genotypes of Japanese encephalitis virus (JEV) are presently recogniz

50 dengue viruses (DENV), West Nile virus, and Japanese encephalitis virus (JEV) are widely used as ser

51 Using Japanese encephalitis virus (JEV) as a model, we perform

52 A yellow fever virus (YFV)/Japanese encephalitis virus (JEV) chimera in which the s

53 In recent years, genotype I (GI) of Japanese encephalitis virus (JEV) has displaced genotype

54 terventions against neurotropic flaviviruses.Japanese encephalitis virus (JEV) is a Flavivirus respon

55 Japanese encephalitis virus (JEV) is the leading global

56 Plasmid vectors containing Japanese encephalitis virus (JEV) premembrane (prM) and

57 e safety and efficacy of the live-attenuated Japanese encephalitis virus (JEV) SA14-14-2 vaccine are

58 tis virus (TBEV), West Nile virus (WNV), and Japanese encephalitis virus (JEV) that could complement

59 Japanese encephalitis virus (JEV), a mosquito-borne flav

60 Japanese encephalitis virus (JEV), although confined to

61 containing EIIIs from Koutango virus (KOUV), Japanese encephalitis virus (JEV), St. Louis encephaliti

62 cation of three flaviviruses, DENV, WNV, and Japanese encephalitis virus (JEV), using a high-content

63 We diagnosed Japanese encephalitis virus (JEV), using antibody detect

64 ENV-1 to DENV-4), West Nile virus (WNV), and Japanese encephalitis virus (JEV), were constructed.

65 c amplification of yellow fever virus (YFV), Japanese encephalitis virus (JEV), West Nile virus (WNV)

66 Japanese encephalitis virus (JEV)-specific Fab antibodie

67 e zoonotic, mosquito-borne disease caused by Japanese encephalitis virus (JEV).

68 le virus (WNV), hepatitis C virus (HCV), and Japanese encephalitis virus (JEV).

69 were vaccinated with yellow fever, chimeric Japanese encephalitis virus (YF/JE), or chimeric West Ni

70 e, yellow fever, tick-borne encephalitis and Japanese encephalitis virus among many others.

71 cryo-electron microscopy structure of mature Japanese encephalitis virus at near-atomic resolution, w

72 es, assessed plasmid VRC5288 (Zika virus and Japanese encephalitis virus chimera), and the VRC 320, d

73 its divergence from the other members of the Japanese encephalitis virus complex, presumably in Afric

74 The global epidemiology of Japanese encephalitis virus has been further clarified.

75 the neurovirulence and neuroinvasiveness of Japanese encephalitis virus in mice.

76 in critical for dengue hemorrhagic fever and Japanese encephalitis virus infection, inhibits NLRP3 in

77 Globally, Japanese encephalitis virus is the most important emergi

78 fferent flaviviruses may cause encephalitis, Japanese encephalitis virus is the most significant, bei

79 DENV NS1 with the corresponding region from Japanese encephalitis virus NS1 to create chimeric DJ NS

80 The presence of dengue virus (DENV) and Japanese encephalitis virus NS1s in the blood of infecte

81 Recent work suggests Japanese encephalitis virus originated in the Indonesia-

82 tick-borne encephalitis virus serogroup) and Japanese encephalitis virus use the nonstructural protei

83 s of the flavivirus family: West Nile virus, Japanese encephalitis virus, and dengue virus 2.

84 yzed by related helicases from Dengue virus, Japanese encephalitis virus, and humans.

85 er (WNF), chikungunya, dengue, yellow fever, Japanese encephalitis virus, GBS, and control datasets.

86 lly include viral (for example, HIV, rabies, Japanese encephalitis virus, herpes simplex virus, varic

87 Louis encephalitis virus, Japanese encephalitis virus, Kunjin virus, Murray Valley

88 erminants of neurovirulence and stability in Japanese encephalitis virus, opening up new avenues for

89 ovirus, metapneumovirus, yellow fever virus, Japanese encephalitis virus, parainfluenza virus and Sen

90 In addition to the plasmids for Japanese encephalitis virus, West Nile virus (WNV), St.

91 milarities to the NS5 protein of the related Japanese encephalitis virus.

92 human pathogens, including dengue virus and Japanese encephalitis virus.

93 fever virus, dengue virus types 2 and 4, and Japanese encephalitis virus.

94 virus genus (including dengue, West Nile and Japanese encephalitis viruses) is regulated by a wide va

95 flaviviruses include dengue, West Nile, and Japanese encephalitis viruses, and the nonpathogenic fla

96 iruses including yellow fever, West Nile and Japanese encephalitis viruses.

97 an epidemic-causing dengue, yellow fever and Japanese encephalitis viruses.

98 laviviruses such as tick-borne encephalitis, Japanese encephalitis, yellow fever and dengue viruses,

99 veloped for generating chimeric yellow fever/Japanese encephalitis (YF/JE) viruses from cDNA template